MEMPHIS, Tenn.–(BUSINESS WIRE)–Sept. 18, 2006–Active Implants Corporation (AIC), a pioneer in pliable orthopaedic implant technology, today announced CE Mark approval for its novel low wear, polymer hip implant which allows the sale of the product throughout Europe.

The AIC Hip Buffer(TM) is a press-fit, low wear polycarbonate polyurethane acetabular cup. This acetabular implant allows for larger femoral head sizes that should enhance joint stability and improve range of motion and shock absorption. The AIC Hip Buffer(TM) has potential applications in both total hip (complete replacement of the joint) and hip resurfacing (replacement of just the surface) surgical procedures, providing a less invasive implant with low wear metal-polymer characteristics. The company will implement a post-approval controlled release of the Hip Buffer(TM).

The AIC Hip Buffer(TM) introduces advanced low wear, pliable materials and innovative implant designs that are less invasive, bone sparing and expected to restore closer to normal joint function. The materials used by AIC are at least 50 times more pliable than all other materials used for this application and can allow for a better and more normal stress transfer to surrounding bone.

“We view this as disruptive technology and are pleased with our progress working closely with leading orthopaedic surgeons on establishing the clinical safety and efficacy of our novel implant technology” said Stephen Bradshaw, President and Chief Executive Officer of AIC. “Following more than a decade of research and development work, the Hip Buffer(TM) marks the beginning of a new generation of resilient implant solutions with a potential broad range of applications in the extremity joints and spine.”

About Active Implants Corporation

Active Implants Corporation is a privately-held company formed in 2004 by an experienced team of orthopaedic executives and inventor with vast experience in advanced, pliable materials. AIC owns a robust intellectual property estate of innovative implant solutions and minimally invasive surgery technology with a potential broad range of medical applications. Headquartered in Memphis, Tennessee, the mission of the company is to serve the emerging “Interventional Arthroplasty” market by providing earlier in life orthopaedic implant solutions.